摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Caffeine 3-hydroxy-2-naphthoic acid | 943529-56-4

中文名称
——
中文别名
——
英文名称
Caffeine 3-hydroxy-2-naphthoic acid
英文别名
3-hydroxynaphthalene-2-carboxylic acid;1,3,7-trimethylpurine-2,6-dione
Caffeine 3-hydroxy-2-naphthoic acid化学式
CAS
943529-56-4
化学式
C8H10N4O2*C11H8O3
mdl
——
分子量
382.376
InChiKey
XCIGJAFPJVYHON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.21
  • 重原子数:
    28
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    116
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    参考文献:
    名称:
    Crystallization at Solvent Interfaces Enables Access to a Variety of Cocrystal Polymorphs and Hydrates
    摘要:
    晶体生长技术,界面共晶,被证明是一种简单有效的制备多组分晶型的方法。该技术基于两种不混溶的共晶形成化合物溶液之间液-液界面的生成,并通过咖啡因共晶多晶型物和水合物的制备证明了其实用性,涉及三种不同的羟基-2-萘甲酸,包括形成一些具有意想不到成分的作品。
    DOI:
    10.1021/acs.cgd.8b00114
点击查看最新优质反应信息

文献信息

  • Microfluidic Approach to Cocrystal Screening of Pharmaceutical Parent Compounds
    作者:Sachit Goyal、Michael R. Thorson、Geoff G. Z. Zhang、Yuchuan Gong、Paul J. A. Kenis
    DOI:10.1021/cg3011212
    日期:2012.12.5
    We describe a microfluidic approach to screen for the formation of cocrystalline solid forms of pharmaceutical parent compounds (PCs). Saturated solutions of PCs and of cocrystal formers dissolved in a variety of solvents are precisely metered in arrays of 48 wells to enable the combinatorial mixing of all possible combinations. Key characteristics of the microfluidic approach, including small quantities (similar to 240 mu g/48 conditions), the ability to generate and screen 48 unique conditions per chip, and the ability to identify solid forms on-chip via Raman spectroscopy, enable solid form screening very early in the drug development process. In contrast, current approaches require on the order of similar to 240 mg for 48 conditions, thus delaying solid form screening to later stages of the drug development. Sequential screening experiments using caffeine as the model compound were conducted to validate the on-chip approach reported here. Preliminary screens were executed to identify conditions with the highest propensity for crystallization and to identify the cocrystal formers (CCFs) resulting in formation of cocrystals via on-chip Raman spectroscopy. Next, the identified, promising conditions were replicated to confirm reproducibility and consistency of the on-chip outcomes. Nine cocrystals of caffeine were identified in this way.
查看更多